Clinical trials
Observational Pleural Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 4 |
| Recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eskisehir Osmangazi University | 3 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| University of Oxford | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Attikon Hospital | 1 |
| Fujirebio Diagnostics, Inc. | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Peking Union Medical College Hospital | 1 |
| Singapore General Hospital | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pleural Diseases | 18 |
| Pleural Effusion | 7 |
| Pleural Neoplasms | 4 |
| Pleural Effusion, Malignant | 3 |
| Lung Neoplasms | 2 |
| Mesothelioma, Malignant | 2 |
| Agnosia | 1 |
| Ascites | 1 |
| Asthma | 1 |
| Bronchiectasis | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.